Financials Shenzhen Lifotronic Technology Co., Ltd.

Equities

688389

CNE100005WZ5

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 06:00:00 2024-07-15 pm EDT 5-day change 1st Jan Change
15.51 CNY -1.34% Intraday chart for Shenzhen Lifotronic Technology Co., Ltd. -2.02% -31.10%

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 8,866 9,711 7,528 9,599 6,645 - -
Enterprise Value (EV) 1 8,866 9,711 7,528 9,599 6,645 6,645 6,645
P/E ratio 61.8 x 51.1 x 29.7 x 29.2 x 15.7 x 12.5 x 10.2 x
Yield - - - 1.25% 2.13% 2.51% 3.09%
Capitalization / Revenue 16 x 12.5 x 7.66 x 8.38 x 4.62 x 3.74 x 3.1 x
EV / Revenue 16 x 12.5 x 7.66 x 8.38 x 4.62 x 3.74 x 3.1 x
EV / EBITDA - 43.8 x 26.9 x 28.1 x 14.8 x 11.5 x 9.47 x
EV / FCF - - - 37.5 x 19.9 x 14.5 x 12.4 x
FCF Yield - - - 2.67% 5.03% 6.89% 8.07%
Price to Book - 7.73 x 5.23 x 5.36 x 3.19 x 2.73 x 2.32 x
Nbr of stocks (in thousands) 422,200 422,200 422,200 426,417 428,429 - -
Reference price 2 21.00 23.00 17.83 22.51 15.51 15.51 15.51
Announcement Date 3/19/21 2/25/22 2/10/23 2/22/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 553.8 778.1 983 1,146 1,440 1,775 2,146
EBITDA 1 - 221.6 280.3 341.6 448.4 579.5 701.4
EBIT 1 - 203.1 256.4 345 448.8 566.7 695.9
Operating Margin - 26.1% 26.08% 30.12% 31.18% 31.93% 32.44%
Earnings before Tax (EBT) 1 - 202.8 256.5 344.5 448.4 566.7 695.8
Net income 1 143.9 190 251.5 328.6 423.4 532.1 649.9
Net margin 25.99% 24.42% 25.58% 28.68% 29.41% 29.97% 30.29%
EPS 2 0.3400 0.4500 0.6000 0.7700 0.9867 1.243 1.517
Free Cash Flow 1 - - - 255.9 334 458 536
FCF margin - - - 22.33% 23.2% 25.8% 24.98%
FCF Conversion (EBITDA) - - - 74.89% 74.49% 79.04% 76.42%
FCF Conversion (Net income) - - - 77.87% 78.88% 86.08% 82.47%
Dividend per Share 2 - - - 0.2810 0.3300 0.3900 0.4800
Announcement Date 3/19/21 2/25/22 2/10/23 2/22/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - - - 256 334 458 536
ROE (net income / shareholders' equity) - 16.1% 18.8% 20.4% 20.4% 21.9% 22.7%
ROA (Net income/ Total Assets) - - - 14% 15.4% 16.6% 17.2%
Assets 1 - - - 2,342 2,750 3,205 3,779
Book Value Per Share 2 - 2.970 3.410 4.200 4.860 5.680 6.690
Cash Flow per Share 2 - 0.4300 0.6400 0.7100 0.7800 1.670 0.7600
Capex 1 - - 184 47.9 117 127 127
Capex / Sales - - 18.67% 4.18% 8.13% 7.15% 5.92%
Announcement Date 3/19/21 2/25/22 2/10/23 2/22/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
15.51 CNY
Average target price
23.86 CNY
Spread / Average Target
+53.87%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688389 Stock
  4. Financials Shenzhen Lifotronic Technology Co., Ltd.